Clinical, laboratory, and autopsy findings support an association between coronavirus
disease-2019 (COVID-19) and thromboembolic disease. Acute COVID-19 infection is …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide
pandemic, and patients with the infection are referred to as having COVID‐19. Although …

Abstract Purpose of Review We aim to provide a comprehensive analysis of
hypercoagulability in individuals affected by COVID-19. Our goal is to describe the …

Background Coagulation abnormalities in COVID-19 patients accompanied with poor
prognosis. This study aimed to determine the prevalence and risk factors of thrombotic …

Introduction Some local protocols suggest using intermediate or therapeutic doses of
anticoagulants for thromboprophylaxis in hospitalized patients with coronavirus disease …

Coronavirus infectious disease-19 (COVID-19) is a pandemic characterized by serious lung
disease and thrombotic events in the venous and circulation trees, which represent a …

Thromboembolism and myocardial injury is common in patients with COVID-19. Low-
molecular-weight heparin appears to be associated with a good prognosis in patients with …

We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …

Thrombotic complications from COVID-19 are now well known and contribute to significant
morbidity and mortality. Different variants confer varying risks of thrombotic complications …

Since the emergence of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-
2) pandemic, an increasing number of reports and studies have tried to warn the medical …